Percutaneous and intra-arterial treatment of hepatocellular carcinoma;Tratamiento percutáneo e intraarterial del carcinoma hepatocelular

Radiologia

Volumn 52, Issue 5, 2010, Pages 399-413

  Real, M I ^a   Bianchi, L ^a   Vilana, R ^a   Burrel, M ^a   Rimola, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Arterial embolization; Chemoembolization; Hepatocellular carcinoma; Intra arterial radiotherapy; Material for embolization; Percutaneous ablation; Tumor response; Tumor staging

Indexed keywords

ABLATION THERAPY; ARTERY CATHETERIZATION; LIVER CELL CARCINOMA; LOCAL THERAPY; REVIEW; TECHNIQUE; THERAPY EFFECT; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 78049258217     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/j.rx.2010.05.002     Document Type: Article

References (73)

1. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
2. A. Forner, C. Ayuso, R.M. Isabel, J. Sastre, R. Robles, and B. Sangro Diagnosis and treatment of hepatocellular carcinoma Med Clin (Barc) 132 2009 272 277
3. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
4. H.L. Liang, C.F. Yang, H.B. Pan, K.H. Lai, J.S. Cheng, and G.H. Lo Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment Radiology 214 2000 769 774
5. C.M. Pacella, G. Francica, F.M. Di Lascio, V. Arienti, E. Antico, and B. Caspani Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis J Clin Oncol 27 2009 2615 2621
6. K. Ohmoto, N. Yoshioka, Y. Tomiyama, N. Shibata, T. Kawase, and K. Yoshida Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas J Gastroenterol Hepatol 24 2009 223 227
7. S. Kerkar, A.M. Carlin, R.L. Sohn, C. Steffes, J. Tyburski, and P. Littrup Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors Surgery 136 2004 770 779
8. L. Zhang, H. Zhu, C. Jin, K. Zhou, K. Li, and H. Su High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins Eur Radiol 19 2009 437 445
9. T. Livraghi, F. Meloni, Stasi M. Di, E. Rolle, L. Solbiati, and C. Tinelli Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47 2008 82 89
10. M. Sala, J.M. Llovet, R. Vilana, L. Bianchi, M. Sole, and C. Ayuso Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology 40 2004 1352 1360
11. M. Ebara, S. Okabe, K. Kita, N. Sugiura, H. Fukuda, and M. Yoshikawa Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation J Hepatol 43 2005 458 464
12. S. Shiina, K. Tagawa, Y. Niwa, T. Unuma, Y. Komatsu, and K. Yoshiura Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients AJR Am J Roentgenol 160 1993 1023 1028 (Pubitemid 23141242)
13. T. Livraghi, A. Giorgio, G. Marin, A. Salmi, Sio I. de, and L. Bolondi Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection Radiology 197 1995 101 108
14. L. Castellano, M. Calandra, B.C. Del Vecchio, and S.I. de Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients J Hepatol 27 1997 862 870
15. R.A. Lencioni, H.P. Allgaier, D. Cioni, M. Olschewski, P. Deibert, and L. Crocetti Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 2003 235 240
16. S.M. Lin, C.J. Lin, C.C. Lin, C.W. Hsu, and Y.C. Chen Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma
17. S.M. Lin, C.J. Lin, C.C. Lin, C.W. Hsu, and Y.C. Chen Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less Gut 54 2005 1151 1156
18. S. Shiina, T. Teratani, S. Obi, S. Sato, R. Tateishi, and T. Fujishima A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 2005 122 130
19. Y.K. Cho, J.K. Kim, M.Y. Kim, H. Rhim, and J.K. Han Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies Hepatology 49 2009 453 459
20. A. Orlando, G. Leandro, M. Olivo, A. Andriulli, and M. Cottone Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials Am J Gastroenterol 104 2009 514 524
21. D. Choi, H.K. Lim, M.J. Kim, S.H. Kim, W.J. Lee, and S.H. Kim Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract AJR Am J Roentgenol 183 2004 1417 1424
22. Y.J. Kim, S.S. Raman, N.C. Yu, R.W. Busuttil, M. Tong, and D.S. Lu Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol 190 2008 1029 1034
23. R. Tateishi, S. Shiina, T. Teratani, S. Obi, S. Sato, and Y. Koike Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 2005 1201 1209 (Pubitemid 40328091)
24. T. Livraghi, S.N. Goldberg, S. Lazzaroni, F. Meloni, T. Ierace, and L. Solbiati Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions Radiology 214 2000 761 768
25. R. Lencioni, L. Crocetti, P. Petruzzi, C. Vignali, E. Bozzi, and P.C. Della Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study J Hepatol 49 2008 217 222
26. Y.J. Zhang, H.H. Liang, M.S. Chen, R.P. Guo, J.Q. Li, and Y. Zheng Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial Radiology 244 2007 599 607
27. R. Lencioni, D. Cioni, L. Crocetti, C. Franchini, C.D. Pina, and J. Lera Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967 (Pubitemid 40250844)
28. T. Livraghi, L. Solbiati, M.F. Meloni, G.S. Gazelle, E.F. Halpern, and S.N. Goldberg Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study Radiology 226 2003 441 451
29. J.M. Llovet, R. Vilana, C. Bru, L. Bianchi, J.M. Salmeron, and L. Boix Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma Hepatology 33 2001 1124 1129
30. M.S. Chen, J.Q. Li, Y. Zheng, R.P. Guo, H.H. Liang, and Y.Q. Zhang A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
31. G.T. Huang, P.H. Lee, Y.M. Tsang, M.Y. Lai, P.M. Yang, and R.H. Hu Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study Ann Surg 242 2005 36 42
32. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
33. D.B. Brown, J.F. Geschwind, M.C. Soulen, S.F. Millward, and D. Sacks Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies J Vasc Interv Radiol 20 2009 S317 S323
34. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, and J. Aponte Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
35. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429 442
36. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, and R.T. Poon Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
37. T. Furuta, E. Maeda, H. Akai, S. Hanaoka, N. Yoshioka, and M. Akahane Hepatic segments and vasculature: projecting CT anatomy onto angiograms Radiographics 29 2009 1 22
38. D.B. Brown, J.F. Cardella, D. Sacks, S.N. Goldberg, D.A. Gervais, and D.K. Rajan Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy J Vasc Interv Radiol 20 2009 S219 S226 S226
39. T. Kanematsu, K. Inokuchi, K. Sugimachi, T. Furuta, T. Sonoda, and S. Tamura Selective effects of Lipiodolized antitumor agents J Surg Oncol 25 1984 218 226
40. L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, and N. Davies Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30 2007 6 25
41. D.B. Brown, T.K. Pilgram, M.D. Darcy, C.E. Fundakowski, M. Lisker-Melman, and W.C. Chapman Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents J Vasc Interv Radiol 16 2005 1661 1666
42. J. Bruix, M. Sala, and J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 2004 S179 S188
43. A.L. Lewis, M.V. Gonzalez, A.W. Lloyd, B. Hall, Y. Tang, and S.L. Willis DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization J Vasc Interv Radiol 17 2006 335 342
44. K. Hong, H. Kobeiter, C.S. Georgiades, M.S. Torbenson, and J.F. Geschwind Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer J Vasc Interv Radiol 16 2005 1711 1717
45. D.A. Leung, J.E. Goin, C. Sickles, B.J. Raskay, and M.C. Soulen Determinants of postembolization syndrome after hepatic chemoembolization J Vasc Interv Radiol 12 2001 321 326
46. N.H. Patel, D. Hahn, S. Rapp, K. Bergan, and D.M. Coldwell Hepatic artery embolization: factors predisposing to postembolization pain and nausea J Vasc Interv Radiol 11 2000 453 460
47. J. Bruix, J.M. Llovet, A. Castells, X. Montana, C. Bru, and M.C. Ayuso Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
48. M. Grosso, C. Vignali, P. Quaretti, A. Nicolini, F. Melchiorre, and G. Gallarato Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study Cardiovasc Intervent Radiol 31 2008 1141 1149
49. K. Malagari, K. Chatzimichael, E. Alexopoulou, A. Kelekis, B. Hall, and S. Dourakis Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 2008 269 280
50. R.T. Poon, W.K. Tso, R.W. Pang, K.K. Ng, R. Woo, and K.S. Tai A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead Clin Gastroenterol Hepatol 5 2007 1100 1108
51. M. Varela, M.I. Real, M. Burrel, A. Forner, M. Sala, and M. Brunet Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 2007 474 481
52. J. Lammer, K. Malagari, T. Vogl, F. Pilleul, A. Denys, and A. Watkinson Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study Cardiovasc Intervent Radiol 2009
53. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
54. A. Veltri, P. Moretto, A. Doriguzzi, E. Pagano, G. Carrara, and G. Gandini Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) Eur Radiol 16 2006 661 669
55. K. Yamakado, A. Nakatsuka, H. Takaki, H. Yokoi, M. Usui, and H. Sakurai Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy Radiology 247 2008 260 266
56. L.M. Kulik, B.I. Carr, M.F. Mulcahy, R.J. Lewandowski, B. Atassi, and R.K. Ryu Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 2008 71 81
57. 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 2005 1627 1639
58. R. Salem, R.J. Lewandowski, M.F. Mulcahy, A. Riaz, R.K. Ryu, and S. Ibrahim Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes Gastroenterology 2009
59. A. Riaz, L. Kulik, R.J. Lewandowski, R.K. Ryu, S.G. Giakoumis, and M.F. Mulcahy Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres Hepatology 49 2009 1185 1193
60. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, L. Rubinstein European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216 (Pubitemid 30099779)
61. S.N. Goldberg, G.S. Gazelle, C.C. Compton, P.R. Mueller, and K.K. Tanabe Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation Cancer 88 2000 2452 2463
62. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, A.K. Burroughs European Association for the Study of the Liver Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference J Hepatol 35 2001 421 430
63. S.N. Goldberg, C.J. Grassi, J.F. Cardella, J.W. Charboneau, G.D. Dodd III, and D.E. Dupuy Image-guided tumor ablation: standardization of terminology and reporting criteria Radiology 235 2005 728 739
64. D. Choi, H.K. Lim, S.H. Kim, W.J. Lee, H.J. Jang, and H. Kim Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent J Ultrasound Med 21 2002 391 401
65. S. Sironi, T. Livraghi, F. Meloni, C.F. De, C. Ferrero, and M.A. Del Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up AJR Am J Roentgenol 173 1999 1225 1229
66. R. Vilana, L. Bianchi, M. Varela, C. Nicolau, M. Sanchez, and C. Ayuso Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16 2006 2454 2462
67. H.K. Lim, D. Choi, W.J. Lee, S.H. Kim, S.J. Lee, and H.J. Jang Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT Radiology 221 2001 447 454
68. S.K. Kim, H.K. Lim, Y.H. Kim, W.J. Lee, S.J. Lee, and S.H. Kim Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings Radiographics 23 2003 107 121
69. K. Ito, K. Honjo, T. Fujita, M. Matsui, H. Awaya, and T. Matsumoto Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology J Comput Assist Tomogr 19 1995 198 203
70. K. Takayasu, S. Arii, N. Matsuo, M. Yoshikawa, M. Ryu, and K. Takasaki Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR Am J Roentgenol 175 2000 699 704
71. I.R. Kamel, D.A. Bluemke, J. Eng, E. Liapi, W. Messersmith, and D.K. Reyes The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma J Vasc Interv Radiol 17 2006 505 512
72. J.A. Vossen, M. Buijs, and I.R. Kamel Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Interv Radiol 9 2006 125 132
73. A.L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, and A.C. Larson Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres AJR Am J Roentgenol 188 2007 768 775